Free Trial

Trellus Health (TRLS) Competitors

GBX 2 +0.20 (+11.11%)
As of 04/17/2025 11:13 AM Eastern

TRLS vs. FDBK, INHC, IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, and RENX

Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include Feedback (FDBK), Induction Healthcare Group (INHC), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), and Renalytix (RENX). These companies are all part of the "health information services" industry.

Trellus Health vs.

Feedback (LON:FDBK) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation, community ranking and institutional ownership.

Feedback received 165 more outperform votes than Trellus Health when rated by MarketBeat users.

CompanyUnderperformOutperform
FeedbackOutperform Votes
165
67.07%
Underperform Votes
81
32.93%
Trellus HealthN/AN/A

Feedback has a net margin of -279.16% compared to Trellus Health's net margin of -12,114.55%. Trellus Health's return on equity of -37.95% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-279.16% -39.71% -22.99%
Trellus Health -12,114.55%-37.95%-22.76%

Feedback has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, Trellus Health has a beta of 0.01, suggesting that its stock price is 99% less volatile than the S&P 500.

Trellus Health has lower revenue, but higher earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than Trellus Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£3.88M1.89-£10.84M-£24.74-0.68
Trellus Health£65.83K58.73-£7.98M-£3.45-0.58

53.2% of Feedback shares are held by institutional investors. Comparatively, 19.3% of Trellus Health shares are held by institutional investors. 10.8% of Feedback shares are held by insiders. Comparatively, 49.7% of Trellus Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Feedback's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company Overall Sentiment
Feedback Neutral
Trellus Health Neutral

Summary

Trellus Health beats Feedback on 7 of the 12 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRLS vs. The Competition

MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£3.87M£193.86M£5.31B£2.51B
Dividend YieldN/A6.68%5.45%4.79%
P/E Ratio-0.58219.1121.94130.39
Price / Sales58.73466.85380.95234,570.21
Price / Cash0.7647.1438.2628.26
Price / Book0.215.096.454.42
Net Income-£7.98M-£15.55M£3.22B£5.88B
1 Month Performance8.81%-3.57%-9.76%-1.35%
1 Year PerformanceN/A6.00%11.49%41.32%

Trellus Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 2
+11.1%
N/A+3.4%£3.87M£65,831.01-0.5831Gap Down
FDBK
Feedback
N/AGBX 16
-2.1%
N/A-84.9%£7.01M£3.88M-0.6524
INHC
Induction Healthcare Group
N/AGBX 5.66
-5.7%
N/A-31.9%£5.22M£12.57M-1.0274
IQAI
IQ-AI
N/AGBX 0.80
+1.9%
N/A-47.4%£1.77M£538,190.00-13.676Positive News
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
1.7284 of 5 stars
GBX 1,570
+4.0%
GBX 2,800
+78.3%
-28.8%£674.58M£230.77M58.01734
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500News Coverage
KOO
Kooth
2.5719 of 5 stars
GBX 133
+3.1%
GBX 583.33
+338.6%
-43.4%£48.81M£50.72M12.50478Earnings Report
Analyst Forecast
News Coverage
RENX
Renalytix
N/AGBX 8.50
+13.3%
N/A-72.4%£35.24M£9.22M-0.40102Gap Up

Related Companies and Tools


This page (LON:TRLS) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners